$2.9 MILLION NCI GRANT AWARDED FOR CLINICAL DEVELOPMENT OF REDHILL'S OPAGANIB AND CAR T-CELL COMBINATION IN ULTRA-HIGH-RISK MULTIPLE MYELOMA

Reuters · 2d ago

Please log in to view news